Literature DB >> 9482809

Vagotomy blocks the induction of interleukin-1beta (IL-1beta) mRNA in the brain of rats in response to systemic IL-1beta.

M K Hansen1, P Taishi, Z Chen, J M Krueger.   

Abstract

There is considerable interest in the mechanisms by which systemic cytokines signal the CNS to elicit centrally controlled biological actions. This study determined the effects of intraperitoneal injections of interleukin-1beta (IL-1beta) on IL-1beta mRNA and IL-1 receptor accessory protein (IL-1RAP) mRNA production in rat liver and brain using the reverse transcription-PCR. Saline or IL-1beta (0.5 microg/kg) was injected intraperitoneally in subdiaphragmatically vagotomized and sham-operated (SHAM) rats. All injections were performed at dark onset, and rats were killed 2 hr after the injection. In SHAM rats, IL-1beta increased IL-1beta mRNA levels in the liver, hypothalamus, hippocampus, and brainstem. Subdiaphragmatic vagotomy blocked the IL-1beta-induced increase in IL-1beta mRNA in the brainstem and hippocampus and significantly attenuated the increase in the hypothalamus. Vagotomy did not affect IL-1beta-induced IL-1beta mRNA production in the liver. IL-1RAP mRNA was highly expressed in each region examined; however, no significant differences in IL-1RAP mRNA production were found in any region after IL-1beta injection. The current results indicate that the vagus nerve is involved in transmitting cytokine signals to the brain and suggest that the induction of brain cytokines is a critical step in the pathway by which vagal-mediated signals result in centrally controlled symptoms of the acute phase response.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9482809      PMCID: PMC6792909     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  46 in total

1.  Vagotomy attenuates but does not prevent the somnogenic and febrile effects of lipopolysaccharide in rats.

Authors:  L Kapás; M K Hansen; H Y Chang; J M Krueger
Journal:  Am J Physiol       Date:  1998-02

2.  Circadian modulation of interleukin-1-induced fever in intact and vagotomized rats.

Authors:  M R Opp; L A Toth
Journal:  Ann N Y Acad Sci       Date:  1997-03-15       Impact factor: 5.691

3.  Rat homolog of mouse interleukin-1 receptor accessory protein: cloning, localization and modulation studies.

Authors:  C Liu; D Chalmers; R Maki; E B De Souza
Journal:  J Neuroimmunol       Date:  1996-05       Impact factor: 3.478

4.  An interleukin-1 receptor fragment inhibits spontaneous sleep and muramyl dipeptide-induced sleep in rabbits.

Authors:  S Takahashi; L Kapás; J Fang; J M Seyer; Y Wang; J M Krueger
Journal:  Am J Physiol       Date:  1996-07

5.  The vagus nerve in the thermoregulatory response to systemic inflammation.

Authors:  A A Romanovsky; C T Simons; M Székely; V A Kulchitsky
Journal:  Am J Physiol       Date:  1997-07

Review 6.  Microbial products and cytokines in sleep and fever regulation.

Authors:  J M Krueger; J A Majde
Journal:  Crit Rev Immunol       Date:  1994       Impact factor: 2.214

7.  Blockade of lipopolysaccharide-induced fever by subdiaphragmatic vagotomy in guinea pigs.

Authors:  E Sehic; C M Blatteis
Journal:  Brain Res       Date:  1996-07-08       Impact factor: 3.252

8.  Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat.

Authors:  G P Smith; C Jerome; B J Cushin; R Eterno; K J Simansky
Journal:  Science       Date:  1981-08-28       Impact factor: 47.728

9.  Thermal and behavioral effects of lipopolysaccharide and influenza in interleukin-1 beta-deficient mice.

Authors:  W Kozak; H Zheng; C A Conn; D Soszynski; L H van der Ploeg; M J Kluger
Journal:  Am J Physiol       Date:  1995-11

10.  Modulation of IL-1 beta gene expression in the rat CNS during sleep deprivation.

Authors:  M Mackiewicz; P J Sollars; M D Ogilvie; A I Pack
Journal:  Neuroreport       Date:  1996-01-31       Impact factor: 1.837

View more
  41 in total

Review 1.  Interoceptive dysfunction: toward an integrated framework for understanding somatic and affective disturbance in depression.

Authors:  Christopher Harshaw
Journal:  Psychol Bull       Date:  2014-11-03       Impact factor: 17.737

2.  Fos expression in the rat brain after intraperitoneal injection of Staphylococcus enterotoxin B and the effect of vagotomy.

Authors:  Xi Wang; Bai-Ren Wang; Xi-Jing Zhang; Xiao-Li Duan; Xiang Guo; Gong Ju
Journal:  Neurochem Res       Date:  2004-09       Impact factor: 3.996

Review 3.  Hypothalamic mechanisms in cachexia.

Authors:  Aaron J Grossberg; Jarrad M Scarlett; Daniel L Marks
Journal:  Physiol Behav       Date:  2010-03-25

4.  Photoperiodic regulation of behavioral responsiveness to proinflammatory cytokines.

Authors:  Jarvi C Wen; Brian J Prendergast
Journal:  Physiol Behav       Date:  2007-01-03

5.  Role of ammonia and inflammation in minimal hepatic encephalopathy.

Authors:  D L Shawcross; G Wright; S W M Olde Damink; R Jalan
Journal:  Metab Brain Dis       Date:  2007-03       Impact factor: 3.584

6.  SLEEP AND CYTOKINES.

Authors:  James M Krueger; David M Rector; Lynn Churchill
Journal:  Sleep Med Clin       Date:  2007

Review 7.  Immune-to-brain signaling: how important are the blood-brain barrier-independent pathways?

Authors:  Ning Quan
Journal:  Mol Neurobiol       Date:  2008-06-19       Impact factor: 5.590

8.  Peripheral interleukin-1β inhibits arcuate kiss1 cells and LH pulses in female mice.

Authors:  Katherine N Makowski; Michael J Kreisman; Richard B McCosh; Ali A Raad; Kellie M Breen
Journal:  J Endocrinol       Date:  2020-08       Impact factor: 4.286

9.  Facilitated acquisition of the classically conditioned eyeblink response in male rats after systemic IL-1beta.

Authors:  Richard J Servatius; Kevin D Beck
Journal:  Integr Physiol Behav Sci       Date:  2003 Jul-Sep

10.  The impact of IL-1 modulation on the development of lipopolysaccharide-induced cognitive dysfunction.

Authors:  Niccolò Terrando; António Rei Fidalgo; Marcela Vizcaychipi; Mario Cibelli; Daqing Ma; Claudia Monaco; Marc Feldmann; Mervyn Maze
Journal:  Crit Care       Date:  2010-05-14       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.